Skip to Content

C 745 (Glipizide Extended Release 5 mg)

Pill with imprint C 745 is Pink, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Par Pharmaceutical, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 745

Glipizide Extended Release

Imprint:
C 745
Strength:
5 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical, Inc.
National Drug Code (NDC):
10370-0745

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide